Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Canopy Growth Corp (NQ: CGC )

3.050 +0.010 (+0.33%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Canopy Growth Corp

< Previous 1 2 3 4 5 6 7 8 9
...
76 77 Next >
Cannabis Growth Q4 Financials Unimpressive
The CEO and CFO believe that Canopy's portfolio of high-impact brands, a rapidly developing U.S. ecosystem and no material debt maturing until 2026 make Canopy well equipped to capitalize on growth... 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Acreage's Q1 Revenue Slips 19% YoY But CEO Foresees 'Significant Growth Opportunities' As Canopy Growth Strategy Moves Forward
Multi-state cannabis operator Acreage Holdings, Inc. (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF), reported on Friday its financial results for the first quarter ended March 31, 2024. "In the first... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Canopy Growth’s Earnings: Profitability Despite Industry Shifts
Canopy Growth's earnings reveal a strategic shift toward profitability, marked by international growth, key acquisitions, and a focus on higher-margin segments. 
Via MarketBeat
Topics Cannabis
Exposures Cannabis
Canopy Growth (CGC) Q4 2024 Earnings Call Transcript
CGC earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
What the Options Market Tells Us About Canopy Gwth
Via Benzinga
What's Going On With Canopy Growth Stock After Earnings?
Canopy Growth Corporation shares are trading higher Thursday after the company reported its fourth-quarter financial results before the market open. Here's a look at what to know. 
Via Benzinga
CGC Stock Earnings: Canopy Growth Misses EPS, Beats Revenue for Q4 2024
CGC stock results show that Canopy Growth missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2024. 
Via InvestorPlace
Is Tilray Brands Preparing for a Big U.S.-Based Acquisition?
Acquisitions have played a big role in Tilray Brands' strategy, and the company is still not done wheeling and dealing. 
Via The Motley Fool
Canopy Growth Reports 7% YoY Increase In Q4 Net Revenue, Continues Focus On Innovation In Canada And International Expansion
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) announced on Thursday financial results for the fourth quarter and fiscal year ended March 31, 2024.Fourth quarter net revenue for the company's... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
What Is Adjusted EBITDA? Here's How The Largest Cannabis Companies Compare
Adjusted EBITDA figures remove non-recurring and irregular items to provide a more accurate way to compare a company's financial health with its peers. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From May 28, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
DEA Rules THCA Is Not Legal Hemp Amid Industry Shake-Up And Farm Bill Debate On Delta-8 THC Prohibition
DEA rules THCA not legal hemp, sparking industry concerns. Congress debates Farm Bill changes. Curaleaf criticizes amendment. Read now! 
Via Benzinga
3 Sorry Cannabis Stocks to Sell in May While You Still Can
Don’t hold these three cannabis stocks any longer, as their unstable financials and unnerving losses scream "sell." 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
House Committee Approval Of Amendment Eliminating 90% Of Hemp-Dervied Products Could Drive Wedge Between Cannabis And Hemp Industries
Via Benzinga
Topics Cannabis
Exposures Cannabis
3 Magnificent Growth Stocks to Buy Hand Over Fist
Small-cap stocks could get a boost from the central bank's anticipated rate cuts in 2025. These three stocks may be a great way to get ahead of this catalyst. 
Via The Motley Fool
Topics Economy
Exposures Interest Rates
Contrarian Bets: 3 Stocks Wall Street Hates That You Should Love
Even though Wall Street doesn't like these companies they are contrarian stocks to buy with significant tailwinds to push them forward. 
Via InvestorPlace
The Canadian Cannabis Report- Monday, May 20
The past, present and future of the Canadian cannabia aector based on the performance of the MCCCI, which is a proprietary index of 14 stocks. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Under $2: Why Are These Small-Cap Shares Up While Broader Sector Is In The Red?
Four lesser-valued cannabis stocks showed positive performance on Monday, defying the broader sector's downtrend. These stocks—Medical Marijuana Inc., TILT Holdings, Trees Corp., and Village Farms... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bearish Monday For Marijuana Stocks - Flower One Hldgs, SOL Glb Inv Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Rallied After Rescheduling News, Investment Management Firm Co-Founder Discusses Impact And Next Steps
Explore how DOJ's cannabis rescheduling boosts stocks and insights from Emily Paxhia on the industry's future. Read now! 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Rescheduling: When Will It Happen? Expert Lays Out Timeline, Risks And Wild Cards
The Department of Justice (DOJ) confirmed that it has started the formal rulemaking process to reclassify cannabis to Schedule III. This significant step reinforces the positive outlook for cannabis... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Is Tilray Brands Stock a Buy?
Despite a broad rally in cannabis, this top Canadian LP has failed to join the party. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Is Aurora Cannabis Stock a Buy?
The company's cost-cutting initiative and pivot to medical cannabis could pay big dividends for patient shareholders. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Canadian Cannabis LPs Portfolio Up 14% This Week; Still Down 21% MTD
The Portfolio was up 14.1% this week but is still finding its level, off almost 21% from its spike from the April 30th DEA announcement. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Benzinga Bulls And Bears: Tesla, GameStop, Tilray And Crypto Trader Says Shiba Inu Could 4X
Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories. The Dow Jones Industrial Average made history on Friday by closing... 
Via Benzinga
Topics Stocks
Exposures US Equities
Should You Buy Canopy Growth (CGC) Stock Before May 30?
While Canopy Growth is in the news thanks to marijuana’s reclassification proposal, CGC stock carries questions ahead of earnings. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
Dear CGC Stock Fans, Mark Your Calendars for May 30
CGC stock continues to climb today following the DOJ's proposal to reschedule cannabis to a Schedule III drug, from a Schedule I. 
Via InvestorPlace
Topics Cannabis
Exposures Cannabis
EXCLUSIVE - System Of A Down's Shavo On Cannabis Rescheduling: 'Still A Long Way To Go But It's A Huge Milestone'
Shavo Odadjian, founder of cannabis brand 22Red and bassist for the heavy metal band System of a Down welcome the recent announcement from President Joe Biden that marijuana will 
Via Benzinga
Topics Cannabis
Exposures Cannabis
What's Going On With Cannabis-Producer Akanda's Stock?
The Department of Justice reportedly planned to issue a notice of proposed rulemaking on Thursday that would reclassify marijuana to Schedule III after a 60-day public comment period. Major players in... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From May 16, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
76 77 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.